REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Clinico Nayibe Cure S.A.S. En Liquidacion (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Laboratorio Clinico Nayibe Cure S.A.S. En Liquidacion Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Laboratorio Clinico Nayibe Cure S.A.S. En Liquidacion is an enterprise based in Colombia. Its main office is in Riohacha. It operates in the Diagnostic Imaging Centers sector. It was incorporated on September 13, 2013. The company’s latest financial report indicates a net sales revenue increase of 200% in 2022. There was a total growth of 68.11% in Laboratorio Clinico Nayibe Cure S.A.S. En Liquidacion’s total assets over the same period. The net profit margin of Laboratorio Clinico Nayibe Cure S.A.S. En Liquidacion increased by 9.8% in 2022.

Headquarters
Cl 5 12 25
Riohacha; La Guajira;

Contact Details: Purchase the Laboratorio Clinico Nayibe Cure S.A.S. En Liquidacion report to view the information.

Basic Information
Outstanding Shares:
Purchase the Laboratorio Clinico Nayibe Cure S.A.S. En Liquidacion report to view the information.
Incorporation Date:
September 13, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio Clinico Nayibe Cure S.A.S. En Liquidacion report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
200%
Total operating revenue
200%
Operating profit (EBIT)
310.28%
EBITDA
304.13%
Net Profit (Loss) for the Period
405.59%
Total assets
68.11%
Total equity
30.94%
Operating Profit Margin (ROS)
7.71%
Net Profit Margin
9.8%
Return on Equity (ROE)
13.16%
Quick Ratio
-0.51%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?